Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature
Rui Bao(Heilongjiang University of Chinese Medicine), Zhaofei Liu(Peking University), Jianhao Lai(Peking University), Jing Huang(Tianjin University of Traditional Chinese Medicine), Zhi Yang(Peking University), Nan Li(People 's Hospital of Jilin Province), Fan Wang(Chinese Academy of Sciences), Yang Zhao(École Polytechnique Fédérale de Lausanne), Suping Li(Jiaxing University), Yanpu Wang(Peking University), Hua Zhu(The Ohio State University Wexner Medical Center)
Cited by 91
Related Papers
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|254